Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPD | P32754 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22977711 | 0.84 | ALDH1A1 (0.41) | KMT2AALDH1A1HPDNPC1PKM | |
| SCHEMBL10754583 | 0.82 | ALDH1A1 (0.46) | KMT2AALDH1A1MAOBNPC1PKM | |
| SCHEMBL21179259 | 0.82 | MEN1 (0.39) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL22977722 | 0.82 | MEN1 (0.39) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL22977718 | 0.73 | CNR2 (0.48) | KMT2AMEN1ALDH1A1MAPT | |
| SCHEMBL3173817 | 0.69 | PARP1 (0.68) | ALDH1A1MAOBNPC1MAPTRAB9A | |
| SCHEMBL10754927 | 0.68 | ENPP3 (0.46) | KMT2AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL3444927 | 0.67 | PARP1 (0.65) | ALDH1A1MAOBNPC1MAPTRAB9A | |
| SCHEMBL3789703 | 0.67 | MAPK8 (0.38) | KMT2AMEN1ALDH1A1NPC1MAPT | |
| SCHEMBL10752526 | 0.67 | MAPT (0.40) | KMT2AMEN1ALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | FMC CORP (US) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | CYP1A2, CYP1B1, CYP1A1 | KMT2A 655/4885MEN1 4471/4885ALDH1A1 257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.